Hahn, L.; Helmrich, N.; Herebian, D.; Mayatepek, E.; Drebber, U.; Domann, E.; Olejniczak, S.; Weigel, M.; Hain, T.; Rath, T. et al.; Wirtz, S.; Mollenkopf, H.-J.; Schmidt, N.; Ewers, C.; Baier, A.; Churin, Y.; Windhorst, A.; Weiskirchen, R.; Steinhoff, U.; Roeb, E.; Roderfeld, M.: IL-13 as Target to Reduce Cholestasis and Dysbiosis in Abcb4 Knockout Mice. Cells 9 (9), 1949 (2020)

Peirasmaki, D.; Ma’ayeh, S. Y.; Xu, F.; Ferella, M.; Campos, S.; Liu, J.; Svärd, S. G.: High Cysteine Membrane Proteins (HCMPs) Are Up-Regulated During Giardia-Host Cell Interactions. Frontiers in Genetics 11, 913 (2020)

Thai, E.; Costa, G.; Weyrich, A.; Murugan, R.; Oyen, D.; Flores-Garcia, Y.; Prieto, K.; Bosch, A.; Valleriani, A.; Wu, N. C. et al.; Pholcharee, T.; Scally, S. W.; Wilson, I. A.; Wardemann, H.; Julien, J.-P.; Levashina, E. A.: A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity. Journal of Experimental Medicine 217 (11), 20200061 (2020)

Graham, S. M.; Agutu, C.; van der Elst, E.; Hassan, A. S.; Gichuru, E.; Mugo, P. M.; Farquhar, C.; Babigumira, J. B.; Goodreau, S. M.; Hamilton, D. T. et al.; Ndung'u, T.; Sirengo, M.; Chege, W.; Sanders, E. J.: A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 9 (8), e16198 (2020)

Graham, S. M.; Agutu, C.; van der Elst, E.; Hassan, A. S.; Gichuru, E.; Mugo, P. M.; Farquhar, C.; Babigumira, J. B.; Goodreau, S. M.; Hamilton, D. T. et al.; Ndung'u, T.; Sirengo, M.; Chege, W.; Sanders, E. J.: A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 9 (8), e16198 (2020)

Jennewein, M. F.; Mabuka, J.; Papia, C. L.; Boudreau, C. M.; Dong, K. L.; Ackerman, M. E.; Ndung'u, T.; Alter, G.: Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection. Frontiers in immunology 11, 1744 (2020)

Charid, I.; Kessler, M.; Darb-Esfahani, S.; Zemojtel, T.; Abobaker, S.; Tyuarets, S.; Schrauwen, S.; Atmani-Kilani, D.; Benaida-Debbache, N.; Schäfer, R. et al.; Castillo-Tong, D. C.; Atmani, D.; Cherbal, F.; h, F. A.; Sehouli, J.; Kulbe, H.; Braicu, E. I.: Pretreatment with methanolic extract of Pistacia lentiscus L. increases sensitivity to DNA damaging drugs in primary high-grade serous ovarian cancer cells. European Journal of Integrative Medicine 37, 101163 (2020)

Charid, I.; Kessler, M.; Darb-Esfahani, S.; Zemojtel, T.; Abobaker, S.; Tyuarets, S.; Schrauwen, S.; Atmani-Kilani, D.; Benaida-Debbache, N.; Schäfer, R. et al.; Castillo-Tong, D. C.; Atmani, D.; Cherbal, F.; Amant, F.; Sehouli, J.; Kulbe, H.; Braicu, E. I.: Pretreatment with methanolic extract of Pistacia lentiscus L. increases sensitivity to DNA damaging drugs in primary high-grade serous ovarian cancer cells. European Journal of Integrative Medicine 37, 101163 (2020)

Mann, J. K.; Rajkoomar, E.; Jin, S. W.; Mkhize, Q.; Baiyegunhi, O.; Mbona, P.; Brockman, M. A.; Ndung'u, T.: Consequences of HLA-associated mutations in HIV-1 subtype C Nef on HLA-I downregulation ability. Journal of medicial virology 92 (8), pp. 1182 - 1190 (2020)

Kasprowicz, V. O.; Chopera, D.; Waddilove, K. D.; Brockman, M. A.; Gilmour, J.; Hunter, E.; Kilembe, W.; Karita, E.; Gaseitsiwe, S.; Sanders, E. J. et al.; Ndung'u, T.: African-led health research and capacity building- is it working? BMC Public Health 20 (1), 1104 (2020)

Kabbert, J.; Benckert, J.; Rollenske, T.; Hitch, T. C. A.; Clavel, T.; Cerovic, V.; Wardemann, H.; Pabst, O.: High microbiota reactivity of adult human intestinal IgA requires somatic mutations. Journal of Experimental Medicine 217 (11) (2020)

Stokic-Trtica, V.; Diefenbach, A.; Klose, C. S. N.: NK Cell Development in Times of Innate Lymphoid Cell Diversity. Frontiers in immunology 11, 813 (2020)

Dziubanska-Kusibab, P. J.; Berger, H.; Battistini, F.; Bouwman, B. A. M.; Iftekhar, A.; Katainen, R.; Cajuso, T.; Crosetto, N.; Orozco, M.; Aaltonen, L. A. et al.; Meyer, T. F.: Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nature Medicine 26 (7), pp. 1063 - 1069 (2020)

Murugan, R.; Scally, S. W.; Costa, G.; Mustafa, G.; Thai, E.; Decker, T.; Bosch, A.; Prieto, K.; Levashina, E. A.; Julien, J.-P. et al.; Wardemann, H.: Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs. Nature Medicine 26 (7), pp. 1135 - 1145 (2020)

Ndlovu, B.; Gounder, K.; Muema, D.; Raju, N.; Hermanus, T.; Mthethwa, Q.; Robertson, K.; Walker, B. D.; Georgiev, I. S.; Morris, L. et al.; Moore, P. L.; Ndung'u, T.: Envelope characteristics in individuals who developed neutralizing antibodies targeting different epitopes in HIV-1 subtype C infection. Virology 546, pp. 1 - 12 (2020)

Otto-Knapp, R.; Häcker, B.; Breuer, C.; Diel, R.; Kaufmann, S. H. E.; Korr, G.; Pfeiffer, M.; Schaberg, T.; Schönfeld, N.; Witte, P. et al.; Bauer, T.: DZK-Stellungnahme zu Tuberkulose, BCG und COVID-19* (*Offizielle Bezeichnung der Erkrankung durch das neuartige Coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus 2) . DZK Recommendations for Tuberculosis, BCG and COVID-19 in Germany (Official Abbreviation of Coronavirus Disease 2019 Caused by the New Coronavirus SARS-CoV-2). Pneumologie 74 (7), pp. 412 - 416 (2020)

Umviligihozo, G.; Cobarrubias, K. D.; Chandrarathna, S.; Jin, S. W.; Reddy, N.; Byakwaga, H.; Muzoora, C.; Bwana, M. B.; Lee, G. Q.; Hunt, P. W. et al.; Martin, J. N.; Brumme, C. J.; Bangsberg, D. R.; Karita, E.; Allen, S.; Hunter, E.; Ndung'u, T.; Brumme, Z. L.; Brockman, M. A.: Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes. Journal of Virology 94 (14), e00293-20 (2020)

Weiner, J.; Domaszewska, T.; Donkor, S.; Kaufmann, S. H. E.; Hill, P. C.; Sutherland, J. S.: Changes in Transcript, Metabolite, and Antibody Reactivity During the Early Protective Immune Response in Humans to Mycobacterium tuberculosis Infection. Clinical Infectious Diseases 71 (1), pp. 30 - 40 (2020)

Sultana, S.; Foti, A.; Dahl, J.-U.: Bacterial Defense Systems against the Neutrophilic Oxidant Hypochlorous Acid. Infection and Immunity 88 (7), e00964-19 (2020)

Barr, D. A.; Lewis, J. M.; Feasey, N.; Schutz, C.; Kerkhoff, A. D.; Jacob, S. T.; Andrews, B.; Kelly, P.; Lakhi, S.; Muchemwa, L. et al.; Bacha, H. A.; Hadad, D. J.; Bedell, R.; van Lettow, M.; Zachariah, R.; Crump, J. A.; Alland, D.; Corbett, E. L.; Krishnamoorthy, G.; Singh, S.; Griesel, R.; Maartens, G.; Mendelson, M.; Ward, A. M.; Parry, C. M.; Talbot, E. A.; Munseri, P.; Dorman, S. E.; Martinson, N.; Shah, M.; Cain, K.; Heilig, C. M.; Varma, J. K.; von Gottberg, A.; Sacks, L.; Wilson, D.; Squire, S. B.; Lalloo, D. G.; Davies, G.; Meintjes, G.: Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infectious Diseases 20 (6), pp. 742 - 752 (2020)